Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2023 16:00 ET | Source: SPHERICAL INSIGHTS LLP

Global Epilepsy Market Size to grow USD 4.7 Billion by 2030 | CAGR of 8.35%: Spherical Insights

New York, United States, March 20, 2023 (GLOBE NEWSWIRE) -- Global Epilepsy Market worth $4.70 Billion by 2030 According to a research report published by Spherical Insights &...
March 03, 2020 08:00 ET | Source: Fluidigm Corporation

Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing

SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
January 07, 2014 08:30 ET | Source: AIM ImmunoTech Inc.

Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) -- Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus

PHILADELPHIA, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced publication of an article entitled "Emergence of a novel drug...
January 24, 2011 04:43 ET | Source: Immune Network Ltd

Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site

VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies, announced...